Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multi-Centre Prospective Community-Based Observational Study on Prediction of Malignant Progression of Clinically Suspicious Oral Lesions With STRATICYTE

NCT04622462 is registered in ClinicalTrials.gov with Proteocyte Diagnostics Inc. as lead sponsor.

NCT NCT04622462
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04622462 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multi-Centre Prospective Community-Based Observational Study on Prediction of Malignant Progression of Clinically Suspicious Oral Lesions With STRATICYTE
Lead sponsor
Proteocyte Diagnostics Inc.
Phase
Observational
Overall status
Recruiting
Start date
March 12, 2015
Completion date
December 31, 2026
Enrollment
500 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

oral neoplasm